Sirnaomics will Present its Innovative Dual-Targeted GalNAc muRNA Programs in 2024 OPT Conference
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, March 12, 2024 /PRNewswire/ -- Sirnaomics Ltd. , a leading biopharmaceutical company engaging in discovery and development of advanced RNAi...
United States Jim Weterings Company Galahead Prnewswire Sirnaomics Ltd Rna Therapeutics Congress Rna Therapeutics Congress Presentation Details
Source: marketscreener.com